IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates20-10-2022
20-10-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates17-10-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates13-10-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Participating in Group Virtual Call with Analyst/Institutional Investors13-10-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a certificate received from M/s. Alankit Assignment Limited, Registrar and Share Transfer Agent of the Company in compliance with the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2022.12-10-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Company has registered with REACH Certificate for Ethyl Acetate (CAS: 141-7-86) with a tonnage band of > 1000 TPA in accordance with EU REACH Regulation on Chemicals and their Safe Use.03-10-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Closure of Trading Window
Notice of closure of trading window29-09-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 22Nd September 2022
Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 22nd September 2022 has inter alia considered and approved to invest US$ 2.1 Million in USpharma Limited an USA based Company subject to compliance with Foreign Exchange Management (Overseas Investment) Rules, 2022 and Foreign Exchange Management (Overseas Investment) Regulations, 2022. USpharma Ltd., is an USA based Company that develop novel drug delivery technologies. The meeting of Board of Directors commenced at 6:00 PM and concluded at 6:42 PM. This is for your information & record.22-09-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201522-09-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Agreement With Media Company.
Dear Sir, This is to inform you that the Company has entered into an Agreement with Adfactors PR Private Limited for providing Public and Investors Relations Services to the Company. The necessary disclosure in terms of Para A of Part A of Schedule III of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 is enclosed herewith as Annexure. This is for your information and records.16-09-2022